qualasept pharmaxo holdings limited
qualasept pharmaxo holdings limited Company Information
Company Number
06981369
Website
bathasu.comRegistered Address
3 corsham science park, park lane, corsham, wiltshire, SN13 9FU
Industry
Activities of head offices
Telephone
01225811131
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
qualasept holdings limited 100%
qualasept pharmaxo holdings limited Estimated Valuation
Pomanda estimates the enterprise value of QUALASEPT PHARMAXO HOLDINGS LIMITED at £9.6m based on a Turnover of £1.7m and 5.83x industry multiple (adjusted for size and gross margin).
qualasept pharmaxo holdings limited Estimated Valuation
Pomanda estimates the enterprise value of QUALASEPT PHARMAXO HOLDINGS LIMITED at £0 based on an EBITDA of £-341k and a 9.99x industry multiple (adjusted for size and gross margin).
qualasept pharmaxo holdings limited Estimated Valuation
Pomanda estimates the enterprise value of QUALASEPT PHARMAXO HOLDINGS LIMITED at £50.1m based on Net Assets of £12.7m and 3.95x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Qualasept Pharmaxo Holdings Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Qualasept Pharmaxo Holdings Limited Overview
Qualasept Pharmaxo Holdings Limited is a live company located in corsham, SN13 9FU with a Companies House number of 06981369. It operates in the activities of head offices sector, SIC Code 70100. Founded in August 2009, it's largest shareholder is qualasept holdings limited with a 100% stake. Qualasept Pharmaxo Holdings Limited is a established, small sized company, Pomanda has estimated its turnover at £1.7m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Qualasept Pharmaxo Holdings Limited Health Check
Pomanda's financial health check has awarded Qualasept Pharmaxo Holdings Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £1.7m, make it smaller than the average company (£20.3m)
£1.7m - Qualasept Pharmaxo Holdings Limited
£20.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 23%, show it is growing at a faster rate (3%)
23% - Qualasept Pharmaxo Holdings Limited
3% - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (33.2%)
100% - Qualasept Pharmaxo Holdings Limited
33.2% - Industry AVG
Profitability
an operating margin of -20.7% make it less profitable than the average company (6%)
-20.7% - Qualasept Pharmaxo Holdings Limited
6% - Industry AVG
Employees
with 8 employees, this is below the industry average (119)
8 - Qualasept Pharmaxo Holdings Limited
119 - Industry AVG
Pay Structure
on an average salary of £162.7k, the company has a higher pay structure (£45.8k)
£162.7k - Qualasept Pharmaxo Holdings Limited
£45.8k - Industry AVG
Efficiency
resulting in sales per employee of £206.6k, this is equally as efficient (£187.7k)
£206.6k - Qualasept Pharmaxo Holdings Limited
£187.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Qualasept Pharmaxo Holdings Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Qualasept Pharmaxo Holdings Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Qualasept Pharmaxo Holdings Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 11 weeks, this is less cash available to meet short term requirements (16 weeks)
11 weeks - Qualasept Pharmaxo Holdings Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.9%, this is a lower level of debt than the average (57.4%)
7.9% - Qualasept Pharmaxo Holdings Limited
57.4% - Industry AVG
qualasept pharmaxo holdings limited Credit Report and Business Information
Qualasept Pharmaxo Holdings Limited Competitor Analysis
Perform a competitor analysis for qualasept pharmaxo holdings limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
qualasept pharmaxo holdings limited Ownership
QUALASEPT PHARMAXO HOLDINGS LIMITED group structure
Qualasept Pharmaxo Holdings Limited has 4 subsidiary companies.
Ultimate parent company
1 parent
QUALASEPT PHARMAXO HOLDINGS LIMITED
06981369
4 subsidiaries
qualasept pharmaxo holdings limited directors
Qualasept Pharmaxo Holdings Limited currently has 5 directors. The longest serving directors include Mr Richard Wastnage (Aug 2009) and Mr Christopher Watt (Aug 2009).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Richard Wastnage | England | 58 years | Aug 2009 | - | Director |
| Mr Christopher Watt | United Kingdom | 55 years | Aug 2009 | - | Director |
| Mrs Alison Davis | England | 50 years | Sep 2016 | - | Director |
| Mr Ian Muir | United Kingdom | 58 years | Apr 2022 | - | Director |
| Mr Andrew Robinson | England | 51 years | Aug 2023 | - | Director |
QUALASEPT PHARMAXO HOLDINGS LIMITED financials
Qualasept Pharmaxo Holdings Limited's latest turnover from December 2022 is £1.7 million and the company has net assets of £12.7 million. According to their latest financial statements, Qualasept Pharmaxo Holdings Limited has 8 employees and maintains cash reserves of £235.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,652,479 | 965,134 | 1,222,642 | 1,040,710 | 888,635 | 848,988 | 152,744,172 | 87,857,054 | 48,687,723 | 30,605,444 | 15,857,894 | 11,285,267 | 9,664,163 | 10,606,641 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 139,959,749 | 76,592,709 | 40,967,913 | 24,282,053 | 11,239,414 | 7,450,697 | 5,948,338 | 6,673,819 |
| Gross Profit | 1,652,479 | 965,134 | 1,222,642 | 1,040,710 | 888,635 | 848,988 | 12,784,423 | 11,264,345 | 7,719,810 | 6,323,391 | 4,618,480 | 3,834,570 | 3,715,825 | 3,932,822 |
| Admin Expenses | 1,994,110 | 889,448 | 1,590,256 | 1,186,998 | 931,388 | 411,041 | 4,653,965 | 7,228,232 | 4,922,990 | 4,181,671 | 3,416,435 | 3,379,138 | 3,219,600 | 2,766,927 |
| Operating Profit | -341,631 | 75,686 | -367,614 | -146,288 | -42,753 | 437,947 | 8,130,458 | 4,036,113 | 2,796,820 | 2,141,720 | 1,202,045 | 455,432 | 496,225 | 1,165,895 |
| Interest Payable | 19,079 | 4,513 | 0 | 9,496 | 67 | 23 | 255,629 | 207,808 | 102,898 | 170,131 | 27,550 | 16,649 | 19,286 | 29,308 |
| Interest Receivable | 525,585 | 127,021 | 224,798 | 160,150 | 44,850 | 0 | 7,939 | 16,957 | 29,865 | 75,841 | 6,533 | 16,414 | 34,915 | 60,949 |
| Pre-Tax Profit | 3,412,240 | 10,848,194 | 4,267,184 | 8,684,366 | 9,167,030 | 5,414,625 | 7,882,768 | 3,845,262 | 2,723,787 | 2,047,430 | 1,181,028 | 455,197 | 511,854 | 1,197,536 |
| Tax | 5,461 | 66,185 | 28,790 | 23,839 | -96 | -83,776 | -1,312,823 | -900,146 | -522,101 | -413,654 | -234,835 | -72,077 | -139,969 | -355,107 |
| Profit After Tax | 3,417,701 | 10,914,379 | 4,295,974 | 8,708,205 | 9,166,934 | 5,330,849 | 6,569,945 | 2,945,116 | 2,201,686 | 1,633,776 | 946,193 | 383,120 | 371,885 | 842,429 |
| Dividends Paid | 3,045,000 | 6,570,000 | 4,410,000 | 4,930,000 | 5,245,000 | 6,475,000 | 250,000 | 2,320,000 | 360,000 | 160,000 | 400,000 | 190,000 | 0 | 0 |
| Retained Profit | 372,701 | 4,344,379 | -114,026 | 3,778,205 | 3,921,934 | -1,144,151 | 6,319,945 | 625,116 | 1,841,686 | 1,473,776 | 546,193 | 193,120 | 371,885 | 842,429 |
| Employee Costs | 1,301,774 | 616,353 | 1,175,510 | 944,434 | 840,793 | 408,576 | 6,035,409 | 5,199,646 | 3,120,534 | 2,495,694 | 1,909,958 | 2,083,783 | 2,089,189 | 1,598,037 |
| Number Of Employees | 8 | 8 | 8 | 8 | 7 | 4 | 156 | 134 | 119 | 77 | 87 | 83 | 69 | 57 |
| EBITDA* | -341,008 | 76,155 | -367,269 | -146,105 | -42,753 | 437,947 | 8,593,364 | 4,269,274 | 3,024,602 | 2,410,633 | 1,500,432 | 737,748 | 743,584 | 1,390,116 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 484 | 1,107 | 1,576 | 756 | 0 | 0 | 6,935,301 | 5,465,715 | 1,349,575 | 519,346 | 604,311 | 684,115 | 752,620 | 807,890 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,464 | 20,929 | 31,453 | 48,196 | 67,940 | 71,789 |
| Investments & Other | 1,003 | 1,005 | 1,005 | 24,501 | 1,005 | 1,003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,487 | 2,112 | 2,581 | 25,257 | 1,005 | 1,003 | 6,935,301 | 5,465,715 | 1,360,039 | 540,275 | 635,764 | 732,311 | 820,560 | 879,679 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 4,579,611 | 3,188,576 | 2,298,562 | 1,820,820 | 901,456 | 628,906 | 603,417 | 559,511 |
| Trade Debtors | 0 | 0 | 0 | 0 | 11,747 | 0 | 17,156,593 | 13,425,882 | 5,467,672 | 4,078,583 | 1,762,463 | 1,067,644 | 1,316,151 | 1,290,692 |
| Group Debtors | 13,238,780 | 12,832,106 | 8,265,030 | 7,328,811 | 4,784,409 | 22,413 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 278,106 | 312,935 | 113,694 | 58,073 | 61,507 | 37,800 | 2,163,922 | 1,659,196 | 886,590 | 524,003 | 471,431 | 327,093 | 99,565 | 170,828 |
| Cash | 235,138 | 149,940 | 138,637 | 1,159,502 | 296,712 | 487,228 | 1,259,349 | 1,073,756 | 743,629 | 319,386 | 1,297,254 | 948,891 | 831,038 | 536,273 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 13,752,024 | 13,294,981 | 8,517,361 | 8,546,386 | 5,154,375 | 547,441 | 25,959,475 | 19,347,410 | 9,396,453 | 6,742,792 | 4,432,604 | 2,972,534 | 2,850,171 | 2,557,304 |
| total assets | 13,753,511 | 13,297,093 | 8,519,942 | 8,571,643 | 5,155,380 | 548,444 | 32,894,776 | 24,813,125 | 10,756,492 | 7,283,067 | 5,068,368 | 3,704,845 | 3,670,731 | 3,436,983 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 7,247,872 | 5,815,112 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,011,736 | 138,152 | 0 | 0 | 0 | 50,000 |
| Trade Creditors | 393 | 204 | 4,950 | 7,938 | 22,305 | 59,738 | 9,498,375 | 9,487,066 | 4,040,142 | 3,455,913 | 1,962,372 | 1,379,685 | 1,231,681 | 1,223,430 |
| Group/Directors Accounts | 570,000 | 570,000 | 76,774 | 117,700 | 473,779 | 83,092 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 937,500 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8,015 |
| other current liabilities | 513,394 | 429,866 | 485,574 | 379,335 | 370,832 | 39,083 | 3,248,771 | 2,855,592 | 818,072 | 706,128 | 551,375 | 287,614 | 590,800 | 579,598 |
| total current liabilities | 1,083,787 | 1,000,070 | 567,298 | 504,973 | 866,916 | 181,913 | 19,995,018 | 18,157,770 | 6,869,950 | 5,237,693 | 2,513,747 | 1,667,299 | 1,822,481 | 1,861,043 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 8,782,995 | 1,105,642 | 0 | 0 | 0 | 0 | 0 | 100,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 244,324 | 85,397 | 21,172 | 21,690 | 4,713 | 33,831 | 37,655 | 37,230 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 9,027,319 | 1,191,039 | 21,172 | 21,690 | 4,713 | 33,831 | 37,655 | 137,230 |
| total liabilities | 1,083,787 | 1,000,070 | 567,298 | 504,973 | 866,916 | 181,913 | 29,022,337 | 19,348,809 | 6,891,122 | 5,259,383 | 2,518,460 | 1,701,130 | 1,860,136 | 1,998,273 |
| net assets | 12,669,724 | 12,297,023 | 7,952,644 | 8,066,670 | 4,288,464 | 366,531 | 3,872,439 | 5,464,316 | 3,865,370 | 2,023,684 | 2,549,908 | 2,003,715 | 1,810,595 | 1,438,710 |
| total shareholders funds | 12,669,724 | 12,297,023 | 7,952,644 | 8,066,670 | 4,288,464 | 366,531 | 3,872,439 | 5,464,316 | 3,865,370 | 2,023,684 | 2,549,908 | 2,003,715 | 1,810,595 | 1,438,710 |
| Dec 2022 | Dec 2021 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -341,631 | 75,686 | -367,614 | -146,288 | -42,753 | 437,947 | 8,130,458 | 4,036,113 | 2,796,820 | 2,141,720 | 1,202,045 | 455,432 | 496,225 | 1,165,895 |
| Depreciation | 623 | 469 | 345 | 183 | 0 | 0 | 462,906 | 222,697 | 217,317 | 258,389 | 281,644 | 262,573 | 227,674 | 210,756 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,464 | 10,465 | 10,524 | 16,743 | 19,743 | 19,685 | 13,465 |
| Tax | 5,461 | 66,185 | 28,790 | 23,839 | -96 | -83,776 | -1,312,823 | -900,146 | -522,101 | -413,654 | -234,835 | -72,077 | -139,969 | -355,107 |
| Stock | 0 | 0 | 0 | 0 | 0 | -4,579,611 | 1,391,035 | 890,014 | 477,742 | 919,364 | 272,550 | 25,489 | 43,906 | 559,511 |
| Debtors | 371,845 | 5,758,157 | 991,840 | 2,529,221 | 4,797,450 | -19,260,302 | 4,235,437 | 8,730,816 | 1,751,676 | 2,368,692 | 839,157 | -20,979 | -45,804 | 1,461,520 |
| Creditors | 189 | -7,734 | -2,988 | -14,367 | -37,433 | -9,438,637 | 11,309 | 5,446,924 | 584,229 | 1,493,541 | 582,687 | 148,004 | 8,251 | 1,223,430 |
| Accruals and Deferred Income | 83,528 | 50,531 | 106,239 | 8,503 | 331,749 | -3,209,688 | 393,179 | 2,037,520 | 111,944 | 154,753 | 263,761 | -303,186 | 11,202 | 579,598 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | -244,324 | 158,927 | 64,225 | -518 | 16,977 | -29,118 | -3,824 | 425 | 37,230 |
| Cash flow from operations | -623,675 | -5,573,020 | -1,227,068 | -2,657,351 | -4,545,983 | 11,301,435 | 2,217,484 | 1,296,967 | 968,738 | 374,194 | 971,220 | 502,155 | 625,391 | 854,236 |
| Investing Activities | ||||||||||||||
| capital expenditure | -9,917,301 | -4,338,837 | -1,047,544 | -173,424 | -201,840 | -194,068 | -188,239 | -313,742 | ||||||
| Change in Investments | -2 | -23,496 | -23,496 | 23,496 | 2 | 1,003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | -9,917,301 | -4,338,837 | -1,047,544 | -173,424 | -201,840 | -194,068 | -188,239 | -313,742 | ||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,011,736 | 1,873,584 | 138,152 | 0 | 0 | -50,000 | 50,000 |
| Group/Directors Accounts | 0 | 452,300 | -40,926 | -356,079 | 390,687 | 83,092 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -937,500 | 937,500 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | -8,782,995 | 7,677,353 | 1,105,642 | 0 | 0 | 0 | 0 | -100,000 | 100,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8,015 | 8,015 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 506,506 | 122,508 | 224,798 | 150,654 | 44,783 | -23 | -247,690 | -190,851 | -73,033 | -94,290 | -21,017 | -235 | 15,629 | 31,641 |
| cash flow from financing | 506,506 | 460,782 | 183,872 | -205,424 | 435,469 | -11,061,683 | -482,159 | -123,115 | 863,051 | -1,018,638 | -21,017 | -235 | -142,386 | 785,937 |
| cash and cash equivalents | ||||||||||||||
| cash | 85,198 | -1,009,562 | -1,020,865 | 862,790 | -190,516 | -772,121 | 185,593 | 330,127 | 424,243 | -977,868 | 348,363 | 117,853 | 294,765 | 536,273 |
| overdraft | 0 | 0 | 0 | 0 | 0 | -7,247,872 | 1,432,760 | 5,815,112 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 85,198 | -1,009,562 | -1,020,865 | 862,790 | -190,516 | 6,475,751 | -1,247,167 | -5,484,985 | 424,243 | -977,868 | 348,363 | 117,853 | 294,765 | 536,273 |
P&L
December 2022turnover
1.7m
+71%
operating profit
-341.6k
-551%
gross margin
100%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
12.7m
+0.03%
total assets
13.8m
+0.03%
cash
235.1k
+0.57%
net assets
Total assets minus all liabilities
qualasept pharmaxo holdings limited company details
company number
06981369
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
August 2009
age
15
accounts
Full Accounts
ultimate parent company
previous names
pharmaxo holdings limited (April 2010)
incorporated
UK
address
3 corsham science park, park lane, corsham, wiltshire, SN13 9FU
last accounts submitted
December 2022
qualasept pharmaxo holdings limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to qualasept pharmaxo holdings limited.
qualasept pharmaxo holdings limited Companies House Filings - See Documents
| date | description | view/download |
|---|
